The FinancialContent Network     SocialPicks Community   |   MarketMinute Monitor   |   MarketMinute Market Updates   |   MarketMinute Stock News
SocialPicks
   Sign Up   |   Log In   |   What is SocialPicks?     

 Acorda Therapeutics Inc.  (ACOR) Trade Now »     Rate ACOR  -  Discuss ACOR  -  Add to Watch List         Graphic_subscribe

       Sector: Healthcare  >  Industry: Biotechnology & Drugs
SocialPicks Sentiment:

** v.s. other stocks
This Quarter's Sentiment:
All:
0.0%
Top:
0.0%
Rate ACOR:


Discuss
        


Arrow_up
Arrow_down
A FREE report on the approval of a new Gout Drug    1 point   Last updated 127 days ago
Posted by
amritadas   N/A
An upcoming treatment by a small cap company for Gout to face FDA decision on approval shortly. Gout has traditionally been a difficult disease to treat. To read about whether this small cap company has chances to get their drug approved, get a FREE report at: http://www.newbiomedicine.com ...  more »
0 Comment  |  Related to:  ACOR

Arrow_up
Arrow_down
A FREE report on the approval of a new Gout Drug    1 point   Last updated 127 days ago
Posted by
amritadas   N/A
FDA Panel to review this Biotech company's stress agent drug on July 28th. If they get a favorable backing by the panel, the chances of approval by the FDA will increase significantly. If the drug gets approved by the FDA, it is estimated to achieve Peak sales of $350 million. To read about our ex... ...  more »
0 Comment  |  Related to:  ACOR


ROCK-STAR INVESTORS
Rank Name Sharpe Ratio Avg Return Followers
1 21.10 +34.44% 381
2 18.14 +71.24% 211
3 17.66 +25.60% 55
4 13.47 +14.32% 62
5 12.13 +74.22% 40


POPULAR STOCKS
Symbol Company Name Sentiment

TODAY'S HEADLINES

TODAY'S TOP PICKS

 

StreetInsider.com on ACOR

Visit streetinsider.com


More Resources

Graphic_arrow1 About Acorda Therapeutics Inc. - Answers.com

Graphic_arrow1 Historical Prices - Yahoo

Graphic_arrow1 Message Boards - BoardCentral.com

Graphic_arrow1 More Info:     Yahoo   |   Google   |   Reuters




IN THE PRESS
Press_forbes Press_washingtonpost Press_wsj Press_npr Press_techcrunch